Leveraging Next-Gen Sequencing, Bioinformatics & -Omics Technologies to Identify & Validate Novel Targets & Regulatory Elements in the Dark Genome
Welcome to the Inaugural Dark Genome Target Discovery & Development Summit
The Dawn of the Dark Genome Has Arrived...
Significant technological advances in computational biology, next-gen sequencing, -omics platforms and AI have unlocked the transformative potential of drug discovery in the dark genome, resulting in investment and partnerships totalling over $1.5 billion in the past 6 months alone.
Designed to bring together the growing community of pioneers, the inaugural Dark Genome Target Discovery & Development Summit is the first industry-focused forum to decipher the mysteries of non-coding DNA and RNA to reveal its role in disease, while uncovering and validating novel targets across oncology, neuroscience, aging, heart disease and beyond!
Featuring a star-studded speaker line-up of ROME Therapeutics, HAYA Therapeutics, Mnemo Therapeutics, Eli Lilly and Company, HERVolution, CAMP4 Therapeutics, Nucleome, Immatics and more, join forces with industry experts across discovery, genomics, proteomics, data science, AI, bioinformatics and computational biology to enlighten a new paradigm for drug discovery.
Discover the Brand-New Program Today
Our World-Class Speaker Faculty Features
Is This Meeting the Right Fit for You?
Seeking an industry-focused learning opportunity to advance your understanding?
Looking to scout out potential partnership opportunities with senior industry leaders?
Brand-new to the space and simply want to know what all the hype is about?
Then you have come to the right place. This June, gain a comprehensive overview of the key learnings, technical challenges, and priorities for drug discovery and development in the dark genome, so you can take actionable insights back to your team.
Connect with key opinion leaders from C-suite to scientist levels working across discovery, bioinformatics, computational biology, AI, data science and -omics, in a collaborative effort to uncover the dark genome’s mysteries, advance technology platforms and propel target discovery.
Meet with 50+ Industry Leaders Including
